Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy
- PMID: 12769761
- DOI: 10.2174/1389201033489856
Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy
Abstract
Infection with human hepatitis C virus (HCV) as a result of a bilateral process of host-virus interactions. There are factors on both sides that contribute to clearance and to chronicity. Virus strategy to survive is built on several basic features. The first, recently recognized, is a wide cell tropism. HCV can infect not only hepatocytes, but also cells of immune system (B-cells, monocytes, macrophages, dendritic cells), epithelium, and immunologically privileged sites such as the central nervous system. Dendritic cells and platelets can also be passive virus carriers. Possibilities of virus clearance or abortive inapparent HCV infection at the stage of adsorption are considered. The second feature is rapid error-prone replication that leads to accumulation within one host of multiple virus variants (quasispecies). Viral heterogeneity could be multiplied by recombination of HCV genomic/subgenomic RNA molecules. Quasispecies nature gives virus an advantage in adaptation to varying host environment including availability of permissive cells, the presence of innate and adaptive immune response, and antiviral treatment. Analysis of HCV polymorphisms and their evolution rates may pinpoint the molecular (sequence) correlates of HCV clearance. The third feature is the capacity to modify or adapt host milieu. HCV core, envelope E2 and nonstructural NS2, NS3, NS5A proteins seem to hold a grip over the host cellular functions by down-regulating processes unfavorable and up-regulating processes favorable for virus replication and persistence. The relevance of the latter interactions to HCV infection outcome remains to be demonstrated. This review discusses recent developments in this area of HCV research.
Similar articles
-
Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.J Virol. 2024 Mar 19;98(3):e0192123. doi: 10.1128/jvi.01921-23. Epub 2024 Feb 6. J Virol. 2024. PMID: 38319104 Free PMC article.
-
Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.J Virol. 2015 Nov;89(21):11056-68. doi: 10.1128/JVI.01964-15. Epub 2015 Aug 26. J Virol. 2015. PMID: 26311867 Free PMC article.
-
Innate and adaptive immune responses in HCV infections.J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. J Hepatol. 2014. PMID: 25443342 Review.
-
Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.Cells. 2019 Apr 25;8(4):376. doi: 10.3390/cells8040376. Cells. 2019. PMID: 31027278 Free PMC article. Review.
-
Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.J Interferon Cytokine Res. 2017 Jun;37(6):278-286. doi: 10.1089/jir.2016.0078. Epub 2017 Apr 25. J Interferon Cytokine Res. 2017. PMID: 28440692
Cited by
-
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.Genet Vaccines Ther. 2009 Jun 8;7:7. doi: 10.1186/1479-0556-7-7. Genet Vaccines Ther. 2009. PMID: 19505299 Free PMC article.
-
Next-generation sequencing reveals large connected networks of intra-host HCV variants.BMC Genomics. 2014;15 Suppl 5(Suppl 5):S4. doi: 10.1186/1471-2164-15-S5-S4. Epub 2014 Jul 14. BMC Genomics. 2014. PMID: 25081811 Free PMC article.
-
Hepatitis C virus antigenic convergence.Sci Rep. 2012;2:267. doi: 10.1038/srep00267. Epub 2012 Feb 15. Sci Rep. 2012. PMID: 22355779 Free PMC article.
-
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.Am J Surg Pathol. 2004 May;28(5):658-69. doi: 10.1097/00000478-200405000-00015. Am J Surg Pathol. 2004. PMID: 15105656 Free PMC article.
-
Efficient error correction for next-generation sequencing of viral amplicons.BMC Bioinformatics. 2012 Jun 25;13 Suppl 10(Suppl 10):S6. doi: 10.1186/1471-2105-13-S10-S6. BMC Bioinformatics. 2012. PMID: 22759430 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous